IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $5 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $5 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.5% | 44.1% | 159.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 5.6% | 20.7% | 55.8% | 74.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6,595.7% | -731.2% | -1,040% | -2,251.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -643.4% | -798.1% | -1,146.1% | -2,442.9% |
| EPS Diluted | -1.07 | -0.15 | -0.2 | -0.15 |
| % Growth | -613.3% | 25% | -33.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |